Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis.
Pulm Pharmacol Ther
; 26(6): 672-6, 2013 Dec.
Article
en En
| MEDLINE
| ID: mdl-23380438
Palabras clave
AE; ELISA; ERS/ATS; European Respiratory Society/American Thoracic Society; FACS; FIH; Fibrocyte; First-in-human clinical trial; IIP; IL-1; IPF; LPS; MCP-1; Macrophage; PBMC; PD; PDGF; PF; PK; PRM-151; PTX-2; Pentraxin-2; Pulmonary fibrosis; SAP; Serum amyloid P; TGF-ß; TNF-α; adverse events; enzyme linked immunoassay; firt-in-human; fluorescence activated cell sorter; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; interleukin-1; lipopolysaccharide; monocyte chemoattractant protein-1; pentraxin-2; peripheral blood mononuclear cell; pharmacodynamics; pharmacokinetics; platelet derived growth factor; pulmonary fibrosis; serum amyloid-P; transforming growth factor-ß; tumor necrosis factor-α
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Fibrosis Pulmonar
/
Componente Amiloide P Sérico
/
Proteínas de Homeodominio
Tipo de estudio:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Pulm Pharmacol Ther
Asunto de la revista:
FARMACOLOGIA
Año:
2013
Tipo del documento:
Article